156 related articles for article (PubMed ID: 2298482)
1. Adherence of Staphylococcus epidermidis to fibrin-platelet clots in vitro mediated by lipoteichoic acid.
Chugh TD; Burns GJ; Shuhaiber HJ; Bahr GM
Infect Immun; 1990 Feb; 58(2):315-9. PubMed ID: 2298482
[TBL] [Abstract][Full Text] [Related]
2. Induction of IL-10-balanced immune profiles following exposure to LTA from Staphylococcus epidermidis.
Volz T; Kaesler S; Draing C; Hartung T; Röcken M; Skabytska Y; Biedermann T
Exp Dermatol; 2018 Apr; 27(4):318-326. PubMed ID: 29569765
[TBL] [Abstract][Full Text] [Related]
3. Bacterial components inhibit fibroblast proliferation in vitro.
Edds EM; Bergamini TM; Brittian KR
ASAIO J; 2000; 46(1):33-7. PubMed ID: 10667713
[TBL] [Abstract][Full Text] [Related]
4. Induction of inflammatory cytokines and nitric oxide in J774.2 cells and murine macrophages by lipoteichoic acid and related cell wall antigens from Staphylococcus epidermidis.
Jones KJ; Perris AD; Vernallis AB; Worthington T; Lambert PA; Elliott TS
J Med Microbiol; 2005 Apr; 54(Pt 4):315-321. PubMed ID: 15770014
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization with lipoteichoic acid and cholera toxin evokes specific pharyngeal IgA and systemic IgG responses and inhibits streptococcal adherence to pharyngeal epithelial cells in mice.
Yokoyama Y; Harabuchi Y
Int J Pediatr Otorhinolaryngol; 2002 May; 63(3):235-41. PubMed ID: 11997159
[TBL] [Abstract][Full Text] [Related]
6. [The effects of lipoteichoic acid and calcium on the adherence of oral streptococci in vitro].
Li M; Liu Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Jan; 31(1):9-11. PubMed ID: 9275604
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus pyogenes clinical isolates and lipoteichoic acid.
Leon O; Panos C
Infect Immun; 1990 Nov; 58(11):3779-87. PubMed ID: 2228247
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of lipoteichoic acid from Staphylococcus aureus on platelet function and platelet-monocyte aggregation.
Wu BQ; Zhi MJ; Liu H; Huang J; Zhou YQ; Zhang TT
Inflamm Res; 2011 Aug; 60(8):775-82. PubMed ID: 21503720
[TBL] [Abstract][Full Text] [Related]
9. Effect of lipoteichoic acid on the uptake of Streptococcus pyogenes by HEp-2 cells.
Sela S; Marouni MJ; Perry R; Barzilai A
FEMS Microbiol Lett; 2000 Dec; 193(2):187-93. PubMed ID: 11111022
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet activity of Staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway.
Sheu JR; Hsiao G; Lee C; Chang W; Lee LW; Su CH; Lin CH
Thromb Res; 2000 Aug; 99(3):249-58. PubMed ID: 10942791
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus lipoteichoic acid inhibits platelet activation and thrombus formation via the Paf receptor.
Waller AK; Sage T; Kumar C; Carr T; Gibbins JM; Clarke SR
J Infect Dis; 2013 Dec; 208(12):2046-57. PubMed ID: 23911710
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic nitric oxide-stimulatory activity of lipoteichoic acids from different Gram-positive bacteria.
Zídek Z; Farghali H; Kmoníčková E
Nitric Oxide; 2010 Dec; 23(4):300-10. PubMed ID: 20850558
[TBL] [Abstract][Full Text] [Related]
13. Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid.
Theilacker C; Kropec A; Hammer F; Sava I; Wobser D; Sakinc T; Codée JD; Hogendorf WF; van der Marel GA; Huebner J
J Infect Dis; 2012 Apr; 205(7):1076-85. PubMed ID: 22362863
[TBL] [Abstract][Full Text] [Related]
14. Lipoteichoic acid inhibits lipopolysaccharide-induced adhesion molecule expression and IL-8 release in human lung microvascular endothelial cells.
Blease K; Chen Y; Hellewell PG; Burke-Gaffney A
J Immunol; 1999 Dec; 163(11):6139-47. PubMed ID: 10570304
[TBL] [Abstract][Full Text] [Related]
15. Equine platelets inhibit E. coli growth and can be activated by bacterial lipopolysaccharide and lipoteichoic acid although superoxide anion production does not occur and platelet activation is not associated with enhanced production by neutrophils.
Aktan I; Dunkel B; Cunningham FM
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):209-17. PubMed ID: 23332730
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets.
Sheu JR; Lee CR; Lin CH; Hsiao G; Ko WC; Chen YC; Yen MH
Thromb Haemost; 2000 May; 83(5):777-84. PubMed ID: 10823277
[TBL] [Abstract][Full Text] [Related]
17. Lipoteichoic acid acts as an antagonist and an agonist of lipopolysaccharide on human gingival fibroblasts and monocytes in a CD14-dependent manner.
Sugawara S; Arakaki R; Rikiishi H; Takada H
Infect Immun; 1999 Apr; 67(4):1623-32. PubMed ID: 10084995
[TBL] [Abstract][Full Text] [Related]
18. Interaction of lipoteichoic acid of group A streptococci with human platelets.
Beachey EH; Chiang TM; Ofek I; Kang AH
Infect Immun; 1977 May; 16(2):649-54. PubMed ID: 324916
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus epidermidis lipoteichoic acid: exocellular release and ltaS gene expression in clinical and commensal isolates.
García-Gómez E; Miranda-Ozuna JFT; Díaz-Cedillo F; Vázquez-Sánchez EA; Rodríguez-Martínez S; Jan-Roblero J; Cancino-Diaz ME; Cancino-Diaz JC
J Med Microbiol; 2017 Jul; 66(7):864-873. PubMed ID: 28639932
[TBL] [Abstract][Full Text] [Related]
20. Kinetic and chemical analyses of the biologic significance of lipoteichoic acids in mediating adherence of serotype III group B streptococci.
Nealon TJ; Mattingly SJ
Infect Immun; 1985 Oct; 50(1):107-15. PubMed ID: 2995256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
